Patent details

EP2501678 Title: ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS

Basic Information

Publication number:
EP2501678
PCT Application Number:
PCT/EP/2010/067536
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107850166
PCT Publication Number:
WO/2011/061168
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS
French Title of Invention:
DÉRIVÉS DE L'ARYLPYRIDINE COMME INHIBITEURS DE L'ALDOSTERONE SYNTHASE.
German Title of Invention:
ARYL-PYRIDIN DERIVATE ALS ALDOSTERON SYNTHASE HEMMER
SPC Number:

Dates

Filing date:
16/11/2010
Grant date:
23/09/2015
EP Publication Date:
23/09/2015
PCT Publication Date:
26/05/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/09/2012
EP B1 Publication Date:
23/09/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/11/2015
Expiration date:
16/11/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/11/2010
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
HU Qi-Ying
Address:
United States (US)

2

Name:
PAPILLON Julien
Address:
United States (US)

3

Name:
CHAMOIN Sylvie
Address:
Switzerland (CH)

4

Name:
IMASE Hidetomo
Address:
United States (US)

5

Name:
ALLAN Martin
Address:
United States (US)

Priority

Priority Number:
261948 P
Priority Date:
17/11/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 213/30;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages